APRIL 2012 Gene-Related Patents Issued - Full patent | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,153,431 | Compositions and methods for making mutations in cell lines and animals | ABT Holding Company | 10-Apr-12 | United States |
8,158,352 | Screening of a novel hepatic syndrome and its uses | Assistance Publique-Hopitaux de Paris | 17-Apr-12 | France |
8,158,595 | Modular aptamer-regulated ribozymes | California Institute of Technology | 17-Apr-12 | United States |
8,148,073 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 3-Apr-12 | Japan |
8,158,350 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 17-Apr-12 | Japan |
8,148,063 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 3-Apr-12 | Japan |
8,163,483 | Compositions and methods for spinocerebellar ataxia | Cedars-Sinai Medical Center | 24-Apr-12 | United States |
8,158,416 | CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins | Crucell Switzerland AG | 17-Apr-12 | Switzerland |
8,158,362 | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype | deCODE Genetics ehf. | 17-Apr-12 | Island |
8,158,391 | Production of an .alpha.-carboxyl-.omega.-hydroxy fatty acid using a genetically modified Candida strain | DNA Twopointo, Inc. | 17-Apr-12 | United States |
8,148,098 | Methods of cleaving DNA with rationally-designed meganucleases | Duke University | 3-Apr-12 | United States |
8,163,514 | Methods of cleaving DNA with rationally-designed meganucleases | Duke University | 24-Apr-12 | United States |
8,163,521 | Self-assembled proteins and related methods and protein structures | Duquesne University of the Holy Ghost | 24-Apr-12 | United States |
8,153,404 | Alleles of the zwf gene from coryneform bacteria | Evonik Degussa GmbH | 10-Apr-12 | Germany |
8,163,492 | Microfluidic device and methods of using same | Fluidign Corporation | 24-Apr-12 | United States |
8,148,072 | Method of profiling gene expression in a subject having heart failure | GeneNews Corporation | 3-Apr-12 | United States |
8,148,076 | Gene expression profiling of EGFR positive cancer | Genomic Health, Inc. | 3-Apr-12 | United States |
8,158,384 | Methods for reducing or eliminating .alpha.-mannosidase resistant glycans in the production of glycoproteins | Glycofi, Inc. | 17-Apr-12 | United States |
8,148,136 | Diagnostics and vaccines for mycobacterial infections of animals and humans | HAV Vaccines Limited | 3-Apr-12 | United Kingdom |
8,153,433 | Mammalian cell lines for increasing longevity and protein yield from a cell culture | Immunomedics, Inc. | 10-Apr-12 | United States |
8,153,413 | High alkaline protease and use thereof | Japan Agency for Marine-Earth Science and Technology | 10-Apr-12 | Japan |
8,153,362 | Mitochondrial function of prohibitin 2 (PHB2) | Jichi Medical University | 10-Apr-12 | Japan |
8,163,525 | Method of expressing long-chain prenyl diphosphate synthase | Kaneka Corporation | 24-Apr-12 | Japan |
8,163,482 | BBS10 related diagnostic methods for Bardet-Biedl syndrome | Katsanis; Nicholas | 24-Apr-12 | United States |
8,148,137 | Mutant microorganism having improved production ability of branched amino acid and method for preparing branched amino acid using the same | Korea Advanced Institute of Science & Technology | 3-Apr-12 | Korea |
8,148,143 | Method and composition for genetically modifying non-human cells and animals | Kwang-Hua Development and Investment Ltd. | 3-Apr-12 | Hong Kong |
8,163,553 | Human trophoblast stem cells and use thereof | Lee; Jau-Nan | 24-Apr-12 | Taiwan |
8,163,473 | Method for using DNA repair capacity as a biomarker of breast cancer risk in women | Matta Murias; Jaime L. | 24-Apr-12 | France |
8,153,402 | Emulsion compositions | Medical Research Council | 10-Apr-12 | United Kingdom |
8,163,506 | Use of toll-like receptor-expressing cells | Meiji Co., Ltd. | 24-Apr-12 | Japan |
8,148,119 | Hydroxylase gene and use thereof | Microbiopharm Japan Co., Ltd. | 3-Apr-12 | Japan |
8,153,364 | Emulsion compositions | MRC | 10-Apr-12 | United Kingdom |
8,148,144 | pCryptoRNAi | National University Corporation Chiba University | 3-Apr-12 | Japan |
8,153,358 | Selection and enrichment of proteins using in vitro compartmentalization | New England Biolabs, Inc. | 10-Apr-12 | United States |
8,158,360 | Effects of inhibitors of FGFR3 on gene transcription | Novartis AG | 17-Apr-12 | Switzerland |
8,163,524 | Comparative analysis of extracellular RNA species | OncoMedx, Inc. | 24-Apr-12 | United States |
8,148,080 | Gene and protein relating to hepatocellular carcinoma and methods of use thereof | Oncotherapy Science, Inc. | 3-Apr-12 | Japan |
8,158,361 | Tumor marker | Qiagen GmbH | 17-Apr-12 | Germany |
8,153,385 | Target protein and target gene in drug designing and screening method | Reverse Proteomics Research Institute Co., Ltd | 10-Apr-12 | Japan |
8,158,351 | Method for determining inflammatory disease | Riken | 17-Apr-12 | Japan |
8,153,399 | Methods and compositions for inactivating glutamine synthetase gene expression | Sangamo Biosciences, Inc. | 10-Apr-12 | United States |
8,163,478 | Fertility restoration for Ogura cytoplasmic male sterile Brassica and method | Syngenta Participations AG | 24-Apr-12 | Switzerland |
8,158,355 | Method to generate or determine nucleic acid tags corresponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal SAGE) | The Agency For Science, Technology and Research | 17-Apr-12 | Singapore |
8,153,372 | Method for simultaneously determining in a single multiplex reaction gender of donors and quantities of genomic DNA and ratios thereof, presence and extent of DNA degradation, and PCR inhibition within a human DNA sample | The Board of Regents for Oklahoma State University | 10-Apr-12 | United States |
8,163,476 | CUDR as biomarker for cancer progression and therapeutic response | The Chinese University of Hong Kong | 24-Apr-12 | China P. Rep. |
8,163,505 | Methods using PBK1 for identifying agents that treat metabolic disorders | The Penn State Research Foundation | 24-Apr-12 | United States |
8,148,124 | Regulation of gene expression by protein methylation | The Regents of the University of California | 3-Apr-12 | United States |
8,148,129 | Generation of potent dominant negative transcriptional inhibitors | The Regents of the University of California | 3-Apr-12 | United States |
8,148,060 | Recombinant viral vector for gene transfer into lymphoid cells | The Research Foudation for Microbial Diseases of Osaka University | 3-Apr-12 | Japan |
8,153,376 | Means and methods for diagnosing and/or treating a subject at risk of developing heart failure | Universiteit Maastricht | 10-Apr-12 | United States |
8,153,366 | Methods and compositions for predicting drug responses | University of Washington | 10-Apr-12 | United States |
8,148,102 | Sequences for FK228 biosynthesis and methods of synthesizing FK228 and FK228 analogs | UWM Research Foundation, Inc. | 3-Apr-12 | United States |
8,153,368 | Four-jointed box (FJX1) in cancer diagnosis and treatment | Vanderbilt University | 10-Apr-12 | United States |
8,153,403 | Process for identifying existence of single nucleotide polymorphism without DNA sequencing | Zainiev; Gafur | 10-Apr-12 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,160,854 | Method of managing and displaying gene expression data | Hitachi Software Engineering Co., Ltd. | 17-Apr-12 | Japan |
8,150,625 | System and method for classifying a body tissue sample | Yissum Research Development Company of the Hebrew University of Jerusalem | 3-Apr-12 | Israel |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,148,344 | Compositions and methods for mediating RNAi in vivo | Alnylam Pharmaceuticals, Inc. | 3-Apr-12 | United States |
8,163,711 | Compositions and methods for inhibiting expression of the HAMP gene | Alnylam Pharmaceuticals, Inc. | 24-Apr-12 | United States |
8,163,280 | Antibodies to c-Met | Amgen Fremont Inc | 24-Apr-12 | United States |
8,147,820 | Attenuated vaccine against fish pathogen Francisella sp | Board of Supervisors of Louisiana State University And Agricultural and Mechanical College | 3-Apr-12 | United States |
8,147,827 | Tumor treatment | Genentech, Inc. | 3-Apr-12 | United States |
8,148,345 | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA | Georgia Health Sciences University Research Institute, Inc. | 3-Apr-12 | United States |
8,153,138 | Recombinant MVA virus | GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH | 10-Apr-12 | Germany |
8,158,600 | Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15) | Inana; George | 17-Apr-12 | United States |
8,148,343 | Tumor suppressor factor | Molecular Discovery Systems | 3-Apr-12 | Australia |
8,148,342 | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases | Quark Pharmaceuticals Inc. | 3-Apr-12 | United States |
8,158,596 | Materials and methods for FOXP3 tumor suppression | The Regents of the University of Michigan | 17-Apr-12 | United States |
8,147,823 | Method of treating or retarding the development of blindness | The Trustees of the University of Pennsylvania | 3-Apr-12 | United States |
8,147,803 | Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof | The University of Houston | 3-Apr-12 | United States |
8,153,110 | Environment-responding siRNA carrier using disulfide-cross-linked polymeric micelle | The University of Tokyo | 10-Apr-12 | Japan |
8,153,116 | Use of conditional plasmodium strains lacking an essential gene in malaria vaccination | University of Connecticut | 10-Apr-12 | United States |
8,153,155 | Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery system | University of Utah | 10-Apr-12 | United States |
8,153,154 | Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery systems | University of Utah | 10-Apr-12 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,148,600 | Immunocompromised rodents as dual color tumor models | Anticancer, Inc. | 3-Apr-12 | United States |
8,153,861 | Genes for improving salt tolerance and drought tolerance of plant and the uses thereof | Biotechnology Research Institute, The Chinese Academy of Agricultural Sciences | 10-Apr-12 | China P. Rep. |
8,163,977 | Extra-cellular matrix localized ferritin for iron uptake, storage, and stress tolerance | Chakraborty; Niranjan | 24-Apr-12 | India |
8,148,605 | Biological systems input-output response system and plant sentinels | Colorado State University Research Foundation | 3-Apr-12 | United States |
8,148,608 | Systems and methods for clonal expression in plants | Fraunhofer USA, Inc | 3-Apr-12 | United States |
8,153,862 | Cytochrome P450 gene for increasing seed size or water stress resistance of plant | Myongji University Industry and Academia Cooperation | 10-Apr-12 | Korea |
8,148,601 | Rice blast susceptibility gene Pi21, resistance gene pi21, and uses thereof | National Institute of Agrobiological Sciences | 3-Apr-12 | Japan |
8,153,858 | Sale of fluorescent transgenic ornamental fish | National University of Singapore | 10-Apr-12 | Singapore |
8,148,604 | Methods and materials for conferring resistance to pests and pathogens of plants | Venganza Inc. | 3-Apr-12 | United States |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,158,754 | Multiple modified derivatives of gelatin and crosslinked material thereof | Bioregen Biomedical (Changzhou) Co., Ltd. | 17-Apr-12 | China P. Rep. |
8,163,883 | Gene encoding labyrinthin, a marker for cancer | Mission Therapeutics, Inc. | 24-Apr-12 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,158,769 | Members of the capsaicin/vanilloid receptor family of proteins and uses thereof | Bayer Schering Pharma Aktiengesellschaft | 17-Apr-12 | Germany |
8,163,709 | TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS | Board of Regents of the University of Texas System | 24-Apr-12 | United States |
8,153,776 | Methods and compositions for RNA interference | Cold Spring Harbor Laboratory | 10-Apr-12 | United States |
8,158,344 | Methods and compositions for correlating genetic markers with multiple sclerosis | Duke University | 17-Apr-12 | United States |
8,153,602 | Composition and methods for the pulmonary delivery of nucleic acids | Isis Pharmaceuticals, Inc. | 10-Apr-12 | United States |
8,153,778 | RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA) | Merck Sharp & Dohme Corp. | 10-Apr-12 | United States |
8,158,772 | Oligonucleotide sequences that identify species of animal | National Institute of Agrobiological Sciences | 17-Apr-12 | Japan |
8,163,894 | DNA for eukaryotic expression of CymR | National Research Council of Canada | 24-Apr-12 | Canada |
8,148,514 | hTERT gene expression regulatory gene | National University Corporation Tottori University | 3-Apr-12 | Japan |
8,148,513 | hTERT gene expression regulatory gene | National University Corporation Tottori University | 3-Apr-12 | Japan |
8,163,892 | Oncolytic virus replicating selectively in tumor cells | Oncolys Biopharma, Inc. | 24-Apr-12 | Japan |
8,163,893 | Pseudotyped retroviral vectors and methods of use thereof | The Regents of the University of Caifornia | 24-Apr-12 | United States |
8,158,766 | Genes with ES cell-specific expression | Yamanaka; Shinya | 17-Apr-12 | Japan |
SURGERY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,150,520 | Methods for catheter-based renal denervation | Ardian, Inc. | 3-Apr-12 | United States |
8,150,519 | Methods and apparatus for bilateral renal neuromodulation | Ardian, Inc. | 3-Apr-12 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.